HPK1-IN-3
HPK1-IN-3 is a potent and selective ATP-competitive hematopoietic progenitor kinase 1 (HPK1; MAP4K1) inhibitor with an IC50 of 0.25 nM. HPK1-IN-3 has IL-2 cellular potency with an EC50 of 108 nM in human peripheral blood mononuclear cells (PBMCs) [1].
Product Specifications
CAS Number
[2739844-34-7]
UNSPSC
12352005
Target
MAP4K
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/hpk1-in-3.html
Purity
98.61
Solubility
DMSO : 83.33 mg/mL (ultrasonic)
Smiles
COC1=C(NC2=NC=C(C(N)=O)C(NC3=C(F)C=CC=C3C(F)(F)F)=N2)C=C4CN(C)CCC4=C1
Molecular Formula
C23H22F4N6O2
Molecular Weight
490.45
References & Citations
[1]Brandon A Vara, et al. Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds. ACS Med Chem Lett. 2021 Mar 19;12 (4) :653-661.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
MAP4K1/HPK1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
E2237-01B 100 µg
EIF2 alpha (Eukaryotic Translation Initiation Factor 2, Subunit 1 alpha, EIF2S1)
Ask
View Details 
GTR15368940 1 Vial
Lentiviral human F11R sgRNA gene knockout kit - Lentiviral human F11R sgRNA gene knockout kit (25)
Ask
View Details 
GTR15085048 1 Vial
Lentiviral human SLC46A1 shRNA (UAS) - Lentiviral human SLC46A1 shRNA (UAS, iRFP) plasmid
Ask
View Details 